VIRX

Viracta Therapeutics, Inc. Common Stock
VIRX

Overview Fund Activity
Delisted

VIRX was delisted on the 3rd of February, 2025.

Back to rankings

33 hedge funds and large institutions have $9M invested in Viracta Therapeutics, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 4 closing their positions.

Holders
33
Holders Change
+5
Holders Change %
+17.86%
% of All Funds
0.59%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
9
Increased
8
Reduced
4
Closed
4
Calls
$327K
Puts
$31K
Net Calls
+$296K
Net Calls Change
+$12K

Top Buyers

1
MIM
1
Monashee Investment Management
Massachusetts
$693K
2
IC
2
Ikarian Capital
Texas
$398K
3
GCP
3
GSA Capital Partners
United Kingdom
$182K
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$671K
5
BFM
5
Boothbay Fund Management
New York
$43K

Top Sellers

1
Citadel Advisors
1
Citadel Advisors
Florida
$62K
2
NCM
2
Nantahala Capital Management
Connecticut
$0
3
Wells Fargo
3
Wells Fargo
California
$78K
4
Group One Trading
4
Group One Trading
Illinois
$18K
5
Millennium Management
5
Millennium Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
SIM
26
Seaview Investment Managers
Florida
$2K +$6 +1 +0.3%
NCM
27
Nantahala Capital Management
Connecticut
– -$865K -197,615 Closed
Millennium Management
28
Millennium Management
New York
– -$26 -5,931 Closed
1
2